EEF1A2 anticorps (Middle Region)
Aperçu rapide pour EEF1A2 anticorps (Middle Region) (ABIN631619)
Antigène
Voir toutes EEF1A2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Specificité
- EEF1 A2 antibody was raised against the middle region of EEF1 2
-
Purification
- Affinity purified
-
Immunogène
- EEF1 A2 antibody was raised using the middle region of EEF1 2 corresponding to a region with amino acids VIDCHTAHIACKFAELKEKIDRRSGKKLEDNPKSLKSGDAAIVEMVPGKP
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
EEF1A2 Blocking Peptide, (ABIN5613306), is also available for use as a blocking control in assays to test for specificity of this EEF1A2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EEF0 2 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- EEF1A2 (Eukaryotic Translation Elongation Factor 1 alpha 2 (EEF1A2))
-
Autre désignation
- EEF1A2
-
Sujet
- EEF1A2 is an isoform of the alpha subunit of the elongation factor-1 complex, which is responsible for the enzymatic delivery of aminoacyl tRNAs to the ribosome. This isoform (alpha 2) is expressed in brain, heart and skeletal muscle, and the other isoform (alpha 1) is expressed in brain, placenta, lung, liver, kidney, and pancreas. This gene may be critical in the development of ovarian cancer. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
-
Poids moléculaire
- 50 kDa (MW of target protein)
Antigène
-